Discriminators between hantavirus-infected and -uninfected persons enrolled in a trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome.
Chapman LE, Ellis BA, Koster FT, Sotir M, Ksiazek TG, Mertz GJ, Rollin PE, Baum KF, Pavia AT, Christenson JC, Rubin PJ, Jolson HM, Behrman RE, Khan AS, Bell LJ, Simpson GL, Hawk J, Holman RC, Peters CJ; Ribavirin Study Group.
Chapman LE, et al. Among authors: pavia at.
Clin Infect Dis. 2002 Feb 1;34(3):293-304. doi: 10.1086/324619. Epub 2001 Dec 13.
Clin Infect Dis. 2002.
PMID: 11774075
Clinical Trial.